Matches in SemOpenAlex for { <https://semopenalex.org/work/W2979402435> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- W2979402435 endingPage "vi133" @default.
- W2979402435 startingPage "vi133" @default.
- W2979402435 abstract "Abstract Background We have applied CyberKnife(CK)-based SBRT to hundreds of patients with primary advanced head and neck cancer (AHNC). Thereby although rarely, we experienced emergence of host-tumor interactions suggestive of immunological modulation among high responders such as the abscopal effect or the emergence of autoimmune diseases reminiscent of irAE. There we reasoned that SBRT did not only ablate tumor but exerted as in situ vaccination. Assuming that, it is rational to combine immunotherapy following SBRT. Objectives Complete cure was obtained in a patient with locally advanced stage IVB maxillary cancer by CK-SBRT with semi-concurrent chemotherapy followed by nivolumab administration. To report clinical consequence. Case report 68 year-old male patient with T4bN2bM0 maxillary SCC with intra-dural and severe orbital involvement was treated by IRB-approved SBRT-based clinical practice. Hypofrartionated SBRT was started from the main lesion, then for two sites of N2b. Two course of S-1 / TXT / CDGP was started from the second half of irradiation. Residual lesions were confirmed by PETCT two months after the end of chemotherapy, and nibormab administration was started. CR was confirmed at PETCT at the time of the administration 6 months after the start of nivolumab. Results Facial edema, eczema and systemic urticaria (Grade 2) were transiently observed but improved by antihistamines and topical steroids. CR of all lesions was achieved. To date there are no signs of recurrence at time that 15 month passed after completion of SBRT. Active social and occupational life of the patient has been realized and maintained. Conclusion Induction SBRT with immediately followed by combination chemotherapy comprised a taxoid and a cisplatin-derivative and subsequent inhibition of PD1/PDL1 axis for residual lesions is feasible and compatible with the current health security system and might be be a most potent strategy for AHNC." @default.
- W2979402435 created "2019-10-18" @default.
- W2979402435 creator A5042677552 @default.
- W2979402435 creator A5070091528 @default.
- W2979402435 date "2019-10-01" @default.
- W2979402435 modified "2023-10-17" @default.
- W2979402435 title "Induction SBRT followed by chemotherapy/immunotherapy for locally advanced maxillary cancer. Case report" @default.
- W2979402435 doi "https://doi.org/10.1093/annonc/mdz343.069" @default.
- W2979402435 hasPublicationYear "2019" @default.
- W2979402435 type Work @default.
- W2979402435 sameAs 2979402435 @default.
- W2979402435 citedByCount "0" @default.
- W2979402435 crossrefType "journal-article" @default.
- W2979402435 hasAuthorship W2979402435A5042677552 @default.
- W2979402435 hasAuthorship W2979402435A5070091528 @default.
- W2979402435 hasBestOaLocation W29794024351 @default.
- W2979402435 hasConcept C121608353 @default.
- W2979402435 hasConcept C126322002 @default.
- W2979402435 hasConcept C143998085 @default.
- W2979402435 hasConcept C2776611710 @default.
- W2979402435 hasConcept C2776694085 @default.
- W2979402435 hasConcept C2777701055 @default.
- W2979402435 hasConcept C2780674031 @default.
- W2979402435 hasConcept C2983288658 @default.
- W2979402435 hasConcept C71924100 @default.
- W2979402435 hasConceptScore W2979402435C121608353 @default.
- W2979402435 hasConceptScore W2979402435C126322002 @default.
- W2979402435 hasConceptScore W2979402435C143998085 @default.
- W2979402435 hasConceptScore W2979402435C2776611710 @default.
- W2979402435 hasConceptScore W2979402435C2776694085 @default.
- W2979402435 hasConceptScore W2979402435C2777701055 @default.
- W2979402435 hasConceptScore W2979402435C2780674031 @default.
- W2979402435 hasConceptScore W2979402435C2983288658 @default.
- W2979402435 hasConceptScore W2979402435C71924100 @default.
- W2979402435 hasLocation W29794024351 @default.
- W2979402435 hasOpenAccess W2979402435 @default.
- W2979402435 hasPrimaryLocation W29794024351 @default.
- W2979402435 hasRelatedWork W1983923482 @default.
- W2979402435 hasRelatedWork W2030612376 @default.
- W2979402435 hasRelatedWork W2078492832 @default.
- W2979402435 hasRelatedWork W2755360248 @default.
- W2979402435 hasRelatedWork W2893846263 @default.
- W2979402435 hasRelatedWork W2996772275 @default.
- W2979402435 hasRelatedWork W3127346141 @default.
- W2979402435 hasRelatedWork W3195008613 @default.
- W2979402435 hasRelatedWork W4214943367 @default.
- W2979402435 hasRelatedWork W4285244024 @default.
- W2979402435 hasVolume "30" @default.
- W2979402435 isParatext "false" @default.
- W2979402435 isRetracted "false" @default.
- W2979402435 magId "2979402435" @default.
- W2979402435 workType "article" @default.